- Home
- KRMD vs CDXS Comparison
KRMD vs CDXS Comparison
Compare KRMD & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- CDXS
- Stock Information
- Founded
- KRMD 1980
- CDXS 2002
- Country
- KRMD United States
- CDXS United States
- Employees
- KRMD N/A
- CDXS N/A
- Industry
- KRMD Medical/Dental Instruments
- CDXS Major Chemicals
- Sector
- KRMD Health Care
- CDXS Industrials
- Exchange
- KRMD Nasdaq
- CDXS Nasdaq
- Market Cap
- KRMD 192.3M
- CDXS 216.6M
- IPO Year
- KRMD N/A
- CDXS 2010
- Fundamental
- Price
- KRMD $4.19
- CDXS $2.64
- Analyst Decision
- KRMD Strong Buy
- CDXS Buy
- Analyst Count
- KRMD 4
- CDXS 2
- Target Price
- KRMD $4.63
- CDXS $11.00
- AVG Volume (30 Days)
- KRMD 93.8K
- CDXS 517.3K
- Earning Date
- KRMD 11-12-2025
- CDXS 10-30-2025
- Dividend Yield
- KRMD N/A
- CDXS N/A
- EPS Growth
- KRMD N/A
- CDXS N/A
- EPS
- KRMD N/A
- CDXS N/A
- Revenue
- KRMD $36,848,451.00
- CDXS $57,164,000.00
- Revenue This Year
- KRMD $21.08
- CDXS $12.88
- Revenue Next Year
- KRMD $16.37
- CDXS $21.64
- P/E Ratio
- KRMD N/A
- CDXS N/A
- Revenue Growth
- KRMD 19.57
- CDXS N/A
- 52 Week Low
- KRMD $1.86
- CDXS $1.90
- 52 Week High
- KRMD $5.05
- CDXS $6.08
- Technical
- Relative Strength Index (RSI)
- KRMD 50.59
- CDXS 52.60
- Support Level
- KRMD $3.78
- CDXS $2.51
- Resistance Level
- KRMD $4.07
- CDXS $2.73
- Average True Range (ATR)
- KRMD 0.15
- CDXS 0.11
- MACD
- KRMD -0.01
- CDXS 0.03
- Stochastic Oscillator
- KRMD 44.23
- CDXS 56.80
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.